SignalCorporate
FTC says ‘pharma bro’ Martin Shkreli repeatedly violated industry ban
FTC alleges Martin Shkreli repeatedly violated an industry ban, signaling regulatory enforcement action.
Context
What happened: The FTC says Martin Shkreli repeatedly violated an industry ban, accusing the convicted felon of trading in dozens of pharmaceutical stocks and sharing opinions on social media.
Why it matters: The FTC's accusation concerns compliance with a ban imposed on Shkreli, a figure known for past pharmaceutical pricing actions.
Coverage: 10 outlets in 24h
What changed
The FTC says Martin Shkreli repeatedly violated an industry ban, accusing the convicted felon of trading in dozens of pharmaceutical stocks and sharing opinions on social media.
Why it matters
The FTC's accusation concerns compliance with a ban imposed on Shkreli, a figure known for past pharmaceutical pricing actions.